<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>WEE1 inhibitors &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/wee1-inhibitors/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 25 Nov 2025 05:36:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>WEE1 inhibitors &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>WEE1 Inhibitors Activate Stress Response via GCN2</title>
		<link>https://bioengineer.org/wee1-inhibitors-activate-stress-response-via-gcn2/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 05:35:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer therapeutics]]></category>
		<category><![CDATA[cell cycle regulation]]></category>
		<category><![CDATA[GCN2 kinase]]></category>
		<category><![CDATA[integrated stress response]]></category>
		<category><![CDATA[WEE1 inhibitors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/wee1-inhibitors-activate-stress-response-via-gcn2/</guid>

					<description><![CDATA[In an exciting advancement for cancer therapeutics and cellular stress biology, a groundbreaking study has unveiled how WEE1 inhibitors activate a critical cellular survival pathway known as the integrated stress response (ISR) through the kinase GCN2. Published in Nature Communications, this research not only expands our understanding of the molecular consequences of WEE1 inhibition but [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">300888</post-id>	</item>
		<item>
		<title>WEE1 Inhibitors Synergize with mRNA Defects via GCN2</title>
		<link>https://bioengineer.org/wee1-inhibitors-synergize-with-mrna-defects-via-gcn2/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 09 Oct 2025 14:51:19 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cancer therapy synergy]]></category>
		<category><![CDATA[GCN2 activation]]></category>
		<category><![CDATA[integrated stress response]]></category>
		<category><![CDATA[mRNA translation defects]]></category>
		<category><![CDATA[WEE1 inhibitors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/wee1-inhibitors-synergize-with-mrna-defects-via-gcn2/</guid>

					<description><![CDATA[In the relentless pursuit of next-generation cancer therapies, a groundbreaking discovery has emerged from the laboratories of Wilson, Zhu, Vinciauskaite, and their colleagues, now published in Nature Communications. Their study unveils a remarkable synergy between WEE1 inhibitors and defects in mRNA translation, mediated through the activation of the integrated stress response kinase GCN2, illuminating new [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">278168</post-id>	</item>
	</channel>
</rss>
